Algae Oil Composition for Joint Pain Alleviation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for joint pain associated with osteoarthritis and rheumatoid arthritis, such as those using krill oil, face challenges in bioavailability and sustainability due to dwindling krill supplies and inefficient omega-3 fatty acid absorption, necessitating a more effective and sustainable alternative.
Innovation Solution
A dietary supplement composition combining algae-based oil rich in phospholipid and glycolipid-bound EPA and DHA with astaxanthin and low molecular weight hyaluronic acid or sodium hyaluronate, which enhances bioavailability and joint health benefits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If krill oil is used to treat joint pain, then anti-inflammatory effects are achieved, but bioavailability is limited and sustainability is compromised due to dwindling krill supplies
Solution Approach 1:
The patent extracts the beneficial active constituents (EPA, DHA, astaxanthin) from krill oil and identifies them as the essential therapeutic components. This allows substitution with alternative sources (algae oil, plant oils) that provide the same active ingredients without depleting krill populations, thus resolving the contradiction between maintaining therapeutic efficacy and ensuring sustainability
Solution Approach 2:
The patent demonstrates that multiple sources (krill oil, algae oil, plant oils) can provide the same beneficial omega-3 fatty acids and antioxidants. This universality allows the therapeutic function to be achieved through various sustainable sources, eliminating dependence on dwindling krill supplies while maintaining anti-inflammatory effects
2Reliability
If krill oil is used to treat joint pain, then anti-inflammatory effects are achieved, but absorption efficiency is insufficient
Solution Approach 1:
The patent changes the chemical form parameters of omega-3 fatty acids by utilizing phospholipid-bound and glycolipid-bound forms in algae-based oils, which have different absorption characteristics than traditional triglyceride forms. This parameter change improves bioavailability and absorption efficiency while maintaining the anti-inflammatory therapeutic effect
Solution Approach 2:
The patent creates a composite formulation combining algae-based oil (with phospholipid and glycolipid-bound EPA/DHA), astaxanthin, and low molecular weight hyaluronic acid. This composite material synergistically enhances absorption efficiency and bioavailability compared to krill oil alone, while providing sustained anti-inflammatory benefits
3Use of energy by moving object
If algae-based oil with phospholipid and glycolipid-bound EPA is used, then bioavailability of omega-3 fatty acids is increased, but formulation complexity increases
Solution Approach 1:
The patent merges multiple beneficial components (algae-based oil with phospholipid/glycolipid-bound EPA, astaxanthin, and low molecular weight hyaluronic acid) into a single integrated formulation. This combination approach simplifies the overall system by consolidating multiple functions into one product, thereby improving bioavailability without proportionally increasing formulation complexity
Data Source
AI summary
A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a patient. The composition includes an algae based oil having glycolipids and phospholipids and Eicosapentaenoic (EPA) fatty acids in combination with astaxanthin and low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan) and a molecular weight less than 300 kilodaltons (kDa) in an oral dosage form.